                         SEQUENCE LISTING

<110>  Fraunhofer-Gesellschaft zur Frderung der angewandten 
       Forschung e.V.
 
<120>  Biological and synthetic molecules inhibiting respiratory 
       syncytial virus infection

<130>  F72325PC

<150>  DE 102019110314.2
<151>  2019-04-18

<160>  46    

<170>  PatentIn version 3.5

<210>  1
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of invention comprising 13 amino acids


<220>
<221>  SITE
<222>  (1)..(1)
<223>  Leu, Val or Ile, or a non-natural or natural analogue thereof

<220>
<221>  SITE
<222>  (2)..(2)
<223>  Val, or a non-natural or natural analogue thereof

<220>
<221>  SITE
<222>  (3)..(3)
<223>  Val, or a non-natural or natural analogue thereof

<220>
<221>  SITE
<222>  (4)..(4)
<223>  natural or non-natural amino acid

<220>
<221>  SITE
<222>  (5)..(5)
<223>  natural or non-natural amino acid

<220>
<221>  SITE
<222>  (6)..(6)
<223>  natural or non-natural amino acid

<220>
<221>  SITE
<222>  (7)..(7)
<223>  Tyr, or a non-natural or natural analogue thereof

<220>
<221>  SITE
<222>  (8)..(8)
<223>  Leu, Val, or Ile, or a non-natural or natural analogue thereof

<220>
<221>  SITE
<222>  (9)..(9)
<223>  Pro, or a non-natural or natural analogue thereof

<220>
<221>  SITE
<222>  (10)..(10)
<223>  natural or non-natural amino acid

<220>
<221>  SITE
<222>  (11)..(11)
<223>  natural or non-natural amino acid

<220>
<221>  SITE
<222>  (12)..(12)
<223>  natural or non-natural amino acid

<220>
<221>  SITE
<222>  (13)..(13)
<223>  Asp or Glu, or a non-natural or natural analogue thereof

<400>  1

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10              


<210>  2
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of invention comprising 14 amino acids


<220>
<221>  SITE
<222>  (1)..(1)
<223>  Leu, Val or Ile, or a non-natural or natural analogue thereof

<220>
<221>  SITE
<222>  (2)..(2)
<223>  Val, or a non-natural or natural analogue thereof

<220>
<221>  SITE
<222>  (3)..(3)
<223>  Val, or a non-natural or natural analogue thereof

<220>
<221>  SITE
<222>  (4)..(4)
<223>  natural or non-natural amino acid

<220>
<221>  SITE
<222>  (5)..(5)
<223>  natural or non-natural amino acid

<220>
<221>  SITE
<222>  (6)..(6)
<223>  natural or non-natural amino acid

<220>
<221>  SITE
<222>  (7)..(7)
<223>  Tyr, or a non-natural or natural analogue thereof

<220>
<221>  SITE
<222>  (8)..(8)
<223>  Leu, Val, or Ile, or a non-natural or natural analogue thereof

<220>
<221>  SITE
<222>  (9)..(9)
<223>  Pro, or a non-natural or natural analogue thereof

<220>
<221>  SITE
<222>  (10)..(10)
<223>  natural or non-natural amino acid

<220>
<221>  SITE
<222>  (11)..(11)
<223>  natural or non-natural amino acid

<220>
<221>  SITE
<222>  (12)..(12)
<223>  natural or non-natural amino acid

<220>
<221>  SITE
<222>  (13)..(13)
<223>  Asp or Glu, or a non-natural or natural analogue thereof

<220>
<221>  SITE
<222>  (14)..(14)
<223>  natural or non-natural amino acid

<400>  2

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  


<210>  3
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Reference peptide with 13 amino acids

<400>  3

Leu Val Val Ser Thr Thr Tyr Leu Pro His Tyr Phe Asp 
1               5                   10              


<210>  4
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 2

<400>  4

Val Val Ser Thr Thr Tyr Leu Pro His Tyr Phe Asp Asn 
1               5                   10              


<210>  5
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Reference peptide with 14 amino acids

<400>  5

Leu Val Val Ser Thr Thr Tyr Leu Pro His Tyr Phe Asp Asn 
1               5                   10                  


<210>  6
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 5

<400>  6

Val Val Val Ser Thr Thr Tyr Leu Pro His Tyr Phe Asp Asn 
1               5                   10                  


<210>  7
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 5

<400>  7

Ile Val Val Ser Thr Thr Tyr Leu Pro His Tyr Phe Asp Asn 
1               5                   10                  


<210>  8
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 5


<220>
<221>  SITE
<222>  (1)..(1)
<223>  Abu

<400>  8

Xaa Val Val Ser Thr Thr Tyr Leu Pro His Tyr Phe Asp Asn 
1               5                   10                  


<210>  9
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of figure 5


<220>
<221>  SITE
<222>  (3)..(3)
<223>  Chg: 2-amino-2-cyclohexylacetic acid

<400>  9

Leu Val Xaa Ser Thr Thr Tyr Leu Pro His Tyr Phe Asp Asn 
1               5                   10                  


<210>  10
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 5


<220>
<221>  SITE
<222>  (7)..(7)
<223>  TYR3-I

<400>  10

Leu Val Val Ser Thr Thr Xaa Leu Pro His Tyr Phe Asp Asn 
1               5                   10                  


<210>  11
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 5


<220>
<221>  SITE
<222>  (1)..(1)
<223>  Chg: 2-amino-2-cyclohexylacetic acid

<220>
<221>  SITE
<222>  (2)..(2)
<223>  Cpa: cyano-propionic amino acid

<220>
<221>  SITE
<222>  (7)..(7)
<223>  TYR3,5-I2

<400>  11

Xaa Xaa Val Ser Thr Thr Xaa Leu Pro His Tyr Phe Asp Asn 
1               5                   10                  


<210>  12
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 5


<220>
<221>  SITE
<222>  (1)..(1)
<223>  Chg: 2-amino-2-cyclohexylacetic acid

<220>
<221>  SITE
<222>  (2)..(2)
<223>  Nle

<220>
<221>  SITE
<222>  (3)..(3)
<223>  Chg: 2-amino-2-cyclohexylacetic acid

<400>  12

Xaa Xaa Xaa Ser Thr Thr Tyr Leu Pro His Tyr Phe Asp Asn 
1               5                   10                  


<210>  13
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 2

<400>  13

Glu Thr Ala Leu Val Val Ser Thr Thr Tyr Leu Pro His Tyr Phe Asp 
1               5                   10                  15      


Asn 
    


<210>  14
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 2

<400>  14

Thr Ala Leu Val Val Ser Thr Thr Tyr Leu Pro His Tyr Phe Asp Asn 
1               5                   10                  15      


<210>  15
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 2

<400>  15

Ala Leu Val Val Ser Thr Thr Tyr Leu Pro His Tyr Phe Asp Asn 
1               5                   10                  15  


<210>  16
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 2

<400>  16

Glu Thr Ala Leu Val Val Ser Thr Thr Tyr Leu Pro His Tyr Phe Asp 
1               5                   10                  15      


<210>  17
<211>  231
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Reference peptide

<400>  17

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Met Val Ser Cys Gln Ala Ser Gly Gly Pro Leu Arg Asn Tyr 
            20                  25                  30          


Ile Ile Asn Trp Leu Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Val Leu Gly Thr Val His Tyr Ala Pro Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Asp Thr Ala Tyr 
65                  70                  75                  80  


Ile His Leu Ile Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Thr Glu Thr Ala Leu Val Val Ser Thr Thr Tyr Leu Pro His Tyr 
            100                 105                 110         


Phe Asp Asn Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser 
        115                 120                 125             


Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr 
    130                 135                 140                 


Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro 
145                 150                 155                 160 


Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val 
                165                 170                 175     


His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser 
            180                 185                 190         


Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile 
        195                 200                 205             


Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys Lys Val 
    210                 215                 220                 


Glu Pro Lys Ser Cys Asp Lys 
225                 230     


<210>  18
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of figure 2

<400>  18

Val Ser Thr Thr Tyr Leu Pro His Tyr Phe Asp Asn 
1               5                   10          


<210>  19
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of figure 2

<400>  19

Ser Thr Thr Tyr Leu Pro His Tyr Phe Asp Asn 
1               5                   10      


<210>  20
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 2

<400>  20

Thr Thr Tyr Leu Pro His Tyr Phe Asp Asn 
1               5                   10  


<210>  21
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 2

<400>  21

Thr Tyr Leu Pro His Tyr Phe Asp Asn 
1               5                   


<210>  22
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 2

<400>  22

Tyr Leu Pro His Tyr Phe Asp Asn 
1               5               


<210>  23
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 2

<400>  23

Leu Pro His Tyr Phe Asp Asn 
1               5           


<210>  24
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 2

<400>  24

Glu Thr Ala Leu Val Val Ser Thr Thr Tyr Leu Pro His Tyr Phe 
1               5                   10                  15  


<210>  25
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 2

<400>  25

Glu Thr Ala Leu Val Val Ser Thr Thr Tyr Leu Pro His Tyr 
1               5                   10                  


<210>  26
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 2

<400>  26

Glu Thr Ala Leu Val Val Ser Thr Thr Tyr Leu Pro His 
1               5                   10              


<210>  27
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 2

<400>  27

Glu Thr Ala Leu Val Val Ser Thr Thr Tyr Leu Pro 
1               5                   10          


<210>  28
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 2

<400>  28

Glu Thr Ala Leu Val Val Ser Thr Thr Tyr 
1               5                   10  


<210>  29
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 2

<400>  29

Glu Thr Ala Leu Val Val Ser Thr Thr 
1               5                   


<210>  30
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 2

<400>  30

Glu Thr Ala Leu Val Val Ser Thr 
1               5               


<210>  31
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 2

<400>  31

Glu Thr Ala Leu Val Val Ser 
1               5           


<210>  32
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 4

<400>  32

Ala Val Val Ser Thr Thr Tyr Leu Pro His Tyr Phe Asp Asn 
1               5                   10                  


<210>  33
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 4

<400>  33

Leu Ala Val Ser Thr Thr Tyr Leu Pro His Tyr Phe Asp Asn 
1               5                   10                  


<210>  34
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 4

<400>  34

Leu Val Ala Ser Thr Thr Tyr Leu Pro His Tyr Phe Asp Asn 
1               5                   10                  


<210>  35
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 4

<400>  35

Leu Val Val Ala Thr Thr Tyr Leu Pro His Tyr Phe Asp Asn 
1               5                   10                  


<210>  36
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 4

<400>  36

Leu Val Val Ser Ala Thr Tyr Leu Pro His Tyr Phe Asp Asn 
1               5                   10                  


<210>  37
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 4

<400>  37

Leu Val Val Ser Thr Ala Tyr Leu Pro His Tyr Phe Asp Asn 
1               5                   10                  


<210>  38
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 4

<400>  38

Leu Val Val Ser Thr Thr Ala Leu Pro His Tyr Phe Asp Asn 
1               5                   10                  


<210>  39
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 4

<400>  39

Leu Val Val Ser Thr Thr Tyr Ala Pro His Tyr Phe Asp Asn 
1               5                   10                  


<210>  40
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Figure 4

<400>  40

Leu Val Val Ser Thr Thr Tyr Leu Ala His Tyr Phe Asp Asn 
1               5                   10                  


<210>  41
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 4

<400>  41

Leu Val Val Ser Thr Thr Tyr Leu Pro Ala Tyr Phe Asp Asn 
1               5                   10                  


<210>  42
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 4

<400>  42

Leu Val Val Ser Thr Thr Tyr Leu Pro His Ala Phe Asp Asn 
1               5                   10                  


<210>  43
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 4

<400>  43

Leu Val Val Ser Thr Thr Tyr Leu Pro His Tyr Ala Asp Asn 
1               5                   10                  


<210>  44
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 4

<400>  44

Leu Val Val Ser Thr Thr Tyr Leu Pro His Tyr Phe Ala Asn 
1               5                   10                  


<210>  45
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 4

<400>  45

Leu Val Val Ser Thr Thr Tyr Leu Pro His Tyr Phe Asp Ala 
1               5                   10                  


<210>  46
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide of Figure 8

<400>  46

Cys Glu Thr Ala Leu Val Val Ser Thr Thr Tyr Leu Pro His Tyr Phe 
1               5                   10                  15      


Asp Asn Cys 
            


